Alzamend Neuro announces death of director Lynne Fahey McGrath on July 20, 2026

Alzamend Neuro, Inc.

Dr. Lynne Fahey McGrath, a director of Alzamend Neuro, passed away on July 20, 2026.
She served on the Board since the company's IPO in June 2021.
Chairman William B. Horne expressed condolences and highlighted her contributions and insights.

item 8.01 item 9.01

Alzamend Neuro, Inc. filing history →

Source: SEC EDGAR

accession 0001214659-26-008772

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.